Cargando…
Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial
BACKGROUND: The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality data and a systematic literature review, we estimated the number of premature deaths that might be a...
Autores principales: | Ker, Katharine, Kiriya, Junko, Perel, Pablo, Edwards, Phil, Shakur, Haleema, Roberts, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314558/ https://www.ncbi.nlm.nih.gov/pubmed/22380715 http://dx.doi.org/10.1186/1471-227X-12-3 |
Ejemplares similares
-
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
por: Ker, Katharine, et al.
Publicado: (2012) -
Cost-Effectiveness Analysis of Administering Tranexamic Acid to
Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial
por: Guerriero, Carla, et al.
Publicado: (2011) -
Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms
por: Roberts, Ian, et al.
Publicado: (2017) -
Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation
por: Guerriero, Carla, et al.
Publicado: (2010) -
Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial
por: Roberts, Ian, et al.
Publicado: (2012)